Search
for
Sort by
Research 781–810 of 1000+
- N6-methyladenosine (m6A)-circHECA facilitates the differentiation of SHF stem cells into hair follicle lineage through miR-449a-5p/LEF1 mediated Wnt/β-catenin pathway in cashmere goats
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Proteomic Analysis of Two Stem Cell Secretomes Used in Combination in a Topical Skin Care Product That Has Demonstrated Efficacy in a Double-Blinded, Vehicle-Controlled Clinical Trial
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- The Role of Janus Kinase Inhibitors in Dermatology
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Black Hairy Tongue Syndrome: Case Report and Review of the Literature
- VITILIGO: WHAT’S OLD, WHAT’S NEW?
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Alopecia Areata
- Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant
- Stem-cell therapy in dermatology – Challenges and opportunities
- Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives
- Autophagy Dysfunction: The Kernel of Hair Loss?
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Targeted immunotherapy for hair regrowth and regeneration
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- Recent advances in the genetics of alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Frontal Fibrosing Alopecia – a review and a practical guide for clinicians
- SnapshotDx Quiz: May 2020
- Alopecia Areata
- JAM-A facilitates hair follicle regeneration in alopecia areata through functioning as ceRNA to protect VCAN expression in dermal papilla cells
- Treatment of pediatric alopecia areata: A systematic review
- Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Prevalence and treatment of Alopecia areata in Taif area, KSA
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient